Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

915
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
915
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

3
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
3
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

3
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

1
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
1

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers for congestion assessment and prognosis in acute heart failure: A systematic review.

Experimental and molecular pathology·2026
Same author

Contrast Media Side Effects and Kounis Syndrome: Timeo Danaos et Dona Ferentes.

Balkan medical journal·2026
Same author

Kounis Syndrome Features in Special Populations.

Medical sciences (Basel, Switzerland)·2026
Same author

Atherosclerosis features in rheumatic diseases - focus on peripheral artery disease.

Frontiers in immunology·2026
Same author

The Nutritional Paradox of Obesity: Mechanisms and Clinical Implications of Micronutrient Deficiencies.

Medical sciences (Basel, Switzerland)·2026
Same author

Influence of Phenotypes on Short-Term Outcomes in Hospitalized Heart Failure with Preserved Ejection Fraction-Insights from a North-Eastern Romanian Cohort.

Medical sciences (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Amiodarone Therapy: Updated Practical Insights.

Victorița Șorodoc1,2, Lucia Indrei3, Catinca Dobroghii1

  • 1Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.

Journal of Clinical Medicine
|October 26, 2024
PubMed
Summary

Amiodarone is a potent antiarrhythmic drug effective for atrial fibrillation and ventricular arrhythmias. Its complex pharmacokinetics and potential side effects necessitate careful management and monitoring for optimal patient outcomes.

Keywords:
QT prolongationamiodaroneamiodarone-induced hypothyroidismamiodarone-induced keratopathyamiodarone-induced pulmonary toxicityamiodarone-induced thyrotoxicosisatrial fibrillationblue-grey syndromeventricular fibrillationventricular tachycardia

More Related Videos

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

391
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

Related Experiment Videos

Last Updated: Jun 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

391
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Amiodarone is a widely used antiarrhythmic medication.
  • It exhibits properties across all four Vaughan Williams antiarrhythmic classes.
  • Effective in managing atrial and ventricular arrhythmias.

Purpose of the Study:

  • To provide a comprehensive review of amiodarone.
  • To cover indications, contraindications, and dosages.
  • To detail drug interactions, side effects, and monitoring.

Main Methods:

  • Literature review of amiodarone's properties.
  • Analysis of pharmacokinetic and pharmacodynamic data.
  • Synthesis of clinical trial and observational data.

Main Results:

  • Amiodarone demonstrates broad antiarrhythmic efficacy.
  • Complex pharmacokinetics with a long half-life.
  • Potential for significant side effects and drug interactions.

Conclusions:

  • Amiodarone requires thorough understanding for safe and effective use.
  • Careful dosage adjustment and monitoring are crucial.
  • Management of side effects and interactions is essential for patient safety.